Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Neuropediatrics ; 55(5): 337-340, 2024 10.
Artículo en Inglés | MEDLINE | ID: mdl-38714209

RESUMEN

Aicardi-Goutières syndrome (AGS) is a rare genetic early-onset progressive encephalopathy with variable clinical manifestations. The IFIH1 mutation has been confirmed to be responsible for type I interferon production and activation of the Janus kinase signaling pathway. We herein stress neurological observations and neuroimaging findings in a severe case report of an infant with AGS type 7 due to an IFIH1 mutation who was diagnosed in the first month of life. We also review neurological characteristics of IFIH1 mutations through recent literature.


Asunto(s)
Enfermedades Autoinmunes del Sistema Nervioso , Helicasa Inducida por Interferón IFIH1 , Mutación , Malformaciones del Sistema Nervioso , Humanos , Helicasa Inducida por Interferón IFIH1/genética , Helicasa Inducida por Interferón IFIH1/inmunología , Enfermedades Autoinmunes del Sistema Nervioso/genética , Enfermedades Autoinmunes del Sistema Nervioso/diagnóstico , Enfermedades Autoinmunes del Sistema Nervioso/complicaciones , Enfermedades Autoinmunes del Sistema Nervioso/fisiopatología , Malformaciones del Sistema Nervioso/genética , Malformaciones del Sistema Nervioso/diagnóstico por imagen , Malformaciones del Sistema Nervioso/complicaciones , Lactante , Masculino
2.
Neuropediatrics ; 50(3): 188-192, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30630214

RESUMEN

BACKGROUND: Brain aneurysms are rare in the pediatric population. The diagnosis of a brain aneurysm in a child may be difficult because of its infrequency and often subtle or nonspecific clinical presentation. Endovascular therapy and microsurgical treatment are increasingly used approaches in treating children, possibly contributing to favorable outcomes if patients are treated in a timely manner. OBJECTIVE: We were interested in the clinical presentation, symptoms, diagnostics, treatment, and follow-up of pediatric patients with brain aneurysms in Slovenia. METHODS: This was a retrospective review of medical documentation of children with intracranial aneurysms treated at the University Children's Hospital in Ljubljana, Slovenia, from January 1998 to December 2017. RESULTS: We identified a cohort of eight children (median age: 14.9 years; range: 2.8-17.7). The estimated incidence of pediatric brain aneurysms in Slovenia is 0.12/100,000 children per year. We observed a male predominance (1.7:1). Half of the patients presented with acute onset of neurologic symptoms and three with subarachnoid hemorrhage. One of the patients had a related stroke. The presenting symptoms were tonic-clonic seizures, hemiparesis, paresthesias, speech disturbance, and cranial nerve palsy. The other half of aneurysms were identified incidentally. Five patients had anterior circulation aneurysms; the most prevalent location was the internal carotid artery. One patient was treated with surgical procedures, four patients were treated with endovascular procedures, and three patients were treated conservatively. Outcome was excellent in all patients. CONCLUSION: Endovascular interventions and microsurgical procedures appear to be safe and effective in the treatment of brain aneurysms in the pediatric population. Asymptomatic patients with brain aneurysms need close follow-up.


Asunto(s)
Aneurisma Intracraneal/diagnóstico por imagen , Aneurisma Intracraneal/epidemiología , Vigilancia de la Población , Adolescente , Niño , Preescolar , Estudios de Cohortes , Procedimientos Endovasculares/métodos , Procedimientos Endovasculares/tendencias , Femenino , Humanos , Aneurisma Intracraneal/cirugía , Masculino , Estudios Retrospectivos , Eslovenia/epidemiología
3.
Radiol Oncol ; 53(4): 388-396, 2019 10 25.
Artículo en Inglés | MEDLINE | ID: mdl-31652121

RESUMEN

Background Childhood and adult-onset craniopharyngioma is a rare embryogenic tumor of the sellar, suprasellar, and parasellar region. Survival rates are high; however, tumor location and treatment sequalae including endocrine deficits, visual impairment, metabolic complications, cognitive and psychosocial deficits can significantly impair patient's quality of life. There is considerable controversy regarding the optimal management of craniopharyngiomas. Subtotal resection of the tumor followed by targeted irradiation to avoid further hypothalamic damage is currently indicated. Novel insights in the tumor's molecular pathology present the possibility for targeted therapy possibly decreasing the rate and severity of treatment-associated morbidity. Conclusions Craniopharyngioma should be seen as a chronic disease. To achieve optimal outcomes a multidisciplinary team of specialized neurosurgeons, neuro-radiologists, neuro-oncologists, pathologists and endocrinologists should be involved in the diagnosis, planning of the surgery, irradiation and long-term follow-up.


Asunto(s)
Craneofaringioma/diagnóstico por imagen , Enfermedades Hipotalámicas/fisiopatología , Hipotálamo/diagnóstico por imagen , Imagen por Resonancia Magnética , Obesidad/fisiopatología , Neoplasias Hipofisarias/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Edad de Inicio , Niño , Craneofaringioma/complicaciones , Craneofaringioma/patología , Craneofaringioma/radioterapia , Progresión de la Enfermedad , Humanos , Enfermedades Hipotalámicas/terapia , Hipotálamo/fisiopatología , Clasificación del Tumor , Obesidad/terapia , Neoplasias Hipofisarias/complicaciones , Neoplasias Hipofisarias/patología , Neoplasias Hipofisarias/radioterapia , Pronóstico , Calidad de Vida , Radiocirugia , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA